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Cells rely on input from extracellular growth factors to
control their proliferation during development and
adult homeostasis. Such mitogenic inputs are trans-
mitted through multiple signaling pathways that
synergize to precisely regulate cell cycle entry and
progression. Although the architecture of these
signaling networks hasbeen characterized inmolecu-
lar detail, their relative contribution, especially at later
cell cycle stages, remains largely unexplored. By
combining quantitative time-resolved measurements
of fluorescent reporters in untransformed human cells
with targeted pharmacological inhibitors and statisti-
cal analysis, we quantify epidermal growth factor
(EGF)-induced signal processing in individual cells
over time and dissect the dynamic contribution of
downstream pathways. We define signaling features
that encode information about extracellular ligand
concentrations and critical timewindows for inducing
cell cycle transitions. We show that both extracellular
signal-regulated kinase (ERK) and phosphatidylinosi-
tol 3-kinase (PI3K) activity are necessary for initial cell
cycle entry, whereas only PI3K affects the duration of
S phase at later stages of mitogenic signaling.
INTRODUCTION
Mammalian cells harbor complex, interlinked signal transduction
networks that relay information from the outside of the cell to the
inside. These networks allow cells to sense fine-grained informa-
tion about their environment and control cellular physiology by
regulating gene expression or influencing processes like cyto-
skeletal organization. However, they are also subject to molecu-
lar noise from cell-intrinsic sources, such as fluctuations in the
levels of signaling proteins, and external influences, such as
changes in their local environment (Snijder and Pelkmans,
2011). Although we have gained a good understanding of theThis is an open access article undmolecular foundation of cellular signaling, we are still challenged
to understand how signaling pathways interact dynamically to
mediate reliable cell fate decisions despite the variable condi-
tions present in individual cells.
Among the most important cellular decisions is the control of
proliferation. In a multicellular organism, the rate and timing of
cell division need to be precisely coordinated to allow growth dur-
ing development and tissue homeostasis during adult life. Cells,
therefore, rely onmitogenic stimuli, such as epidermal growth fac-
tor (EGF) and their respective receptors, to initiate cell cycle entry.
A crucial mediator of mitogenic signals is the mitogen-activated
protein kinase (MAPK) pathway (Seger and Krebs, 1995; Fig-
ure 1A): activation of the EGF receptor (EGFR) and the small
GTPase RAS induces phosphorylation and activation of the ki-
nases rapidly accelerated fibrosarcoma (RAF),MAPK/ERK kinase
(MEK), and extracellular signal-regulated kinase (ERK). Upon
phosphorylation, ERK translocates to the nucleus and activates
transcription of target genes. Among the first target genes ex-
pressed is the transcription factor FOS. In addition to activating
its mRNA expression, ERK phosphorylates and stabilizes the
FOS protein. Therefore, target genes of FOS, such as FRA1/
FOSL1, which is also stabilized by ERK phosphorylation, will be
induced only by prolonged activity of ERK (Marshall, 1995). In
addition to this temporal encoding, information in the MAPK
pathway may be encoded by the amplitude and duration of the
signal (Heinrich et al., 2002) or other features like frequency and
amplitude of oscillation in the localization of ERK (Shankaran
et al., 2009). ERK promotes proliferation by inducing expression
of Cyclin D and repression of cyclin-dependent kinase (CDK) in-
hibitors (Rubinfeld and Seger, 2005; Zhang and Liu, 2002). Upon
activation, CDKs phosphorylate the retinoblastoma protein and
release E2F transcription factors, which regulate complex
changes in cellular physiology that mark the transition from G1
to S phase of the cell cycle (Harbour and Dean, 2000; Yao et al.,
2008). Other signaling-induced processes, such as expression
and stabilization of c-myc, contribute to regulating the G1 to S
phase transition (Leung et al., 2008).
In addition to the MAPK pathway, EGFR also activates the
PI3K/AKT pathway through direct or indirect recruitment and
activation of the p85/p110 kinase complex. PI3K activity leadsCell Reports 31, 107514, April 14, 2020 ª 2020 The Author(s). 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
to the generation of phosphatidylinositol-3,4,5-triphosphate,
which in turn recruits the kinase AKT to the membrane, where
it is activated by PDK1. Through activation of mechanistic target
of rapamycin kinase (mTOR), AKT influences translation and
contributes to Cyclin D accumulation during cell cycle entry
(Hay and Sonenberg, 2004). In addition, AKT also mediates
inhibitory phosphorylation of the Cyclin D repressor FOXO
(Schmidt et al., 2002) and the kinase GSK3beta, which induces
Cyclin D degradation (Dong et al., 2005). Furthermore, AKT
signaling may contribute to other cell cycle transitions by
affecting the activity and localization of regulatory proteins and
controlling metabolism (Ward and Thompson, 2012). The PI3K
andMAPK pathways interact closely upon mitogenic stimulation
(Chen et al., 2012; Moelling et al., 2002). It has been suggested
that both pathways are compensatory through co-regulated
proteins (Zwang et al., 2011). Other reports indicate that AKT
negatively regulates MAPK activity through inactivation of RAF
(Zimmermann and Moelling, 1999), whereas MEK suppresses
PI3K signaling by promoting membrane localization of the phos-
phatase PTEN (Zmajkovicova et al., 2013).
In summary, the importance and synergy of ERK and AKT in
initiating the cell cycle from G0 to S phase has been well re-
searched, such as the mechanisms by which these pathways
interact in controlling Cyclin D. In contrast, the relative roles of
AKT and ERK in controlling later stages are less clear. We, there-
fore, set out to investigate the temporal role of ERK and its rela-
tive importance to other pathways in cell cycle control
throughout the cell cycle. To this end, we quantified EGF-
induced mitogenic signaling and deconvolved the dynamic con-
tributions of downstream signaling pathways by combining time-
resolved single-cell measurements of ERK activity and cell cycle
progression in an untransformed human cell line with targeted
pharmacological perturbations and statistical analysis. Using
this approach, we define features of ERK activity that encode in-
formation about extracellular ligand concentration and deter-
mine the time window where it is necessary for cell cycle entry.
We show that both ERK and PI3K activity are necessary for initial
cell cycle entry, whereas only PI3K affects the duration of S
phase at later stages of the mitogenic signaling.
RESULTS
Quantitative Live-Cell Imaging Reveals Cell-Specific
Activation Patterns of the EGFR/ERK Pathway
To analyze EGF-induced signaling in living cells on physiologically
relevant timescales, we used a previously established MCF10A
reporter cell line. This reporter termed FIRE is based on the fluo-
rescent protein mVenus fused to a nuclear localization signal and
the PESTdomain of FRA1, a transcription factor stabilized byERK
phosphorylation (Albeck et al., 2013; Figures 1A and S1A). In the
absence of mitogenic stimuli activating the EGFR/ERK pathway,
the constitutively expressed reporter is rapidly degraded. When
cells are treated with EGF, FIRE is stabilized through ERK-depen-
dent phosphorylation and accumulates in the nucleus (Figure 1B).
It, therefore, provides a specific linear measure of the integrated
activity of the EGFR/ERK pathway over long, physiologically rele-
vant timescales (Gillies et al., 2017), whichwe verified using small-
molecule inhibitors (Figures S1B and S1C).2 Cell Reports 31, 107514, April 14, 2020As we were mainly interested in following mitogenic signaling
during the progression of quiescent cells from the G0 phase of
the cell cycle to mitosis, we withdrew mitogenic growth factors
and serum for 48 h before stimulating reporter cells with
defined EGF doses spanning two orders of magnitude from
0.5 ng/ml to 50 ng/ml. We then measured the nuclear fluores-
cence intensity of FIRE for 48 h and generated time-resolved
trajectories of FIRE intensity, representing more than 850 indi-
vidual cells per condition by using automated image analysis
followed by data processing and normalization (Figures S1D
and S1E; STAR Methods; Table S1). Without EGF, cells
showed no detectable changes in reporter activity, indicating
that there was no residual input to the MAPK pathway under
our experimental conditions (Figures 1B and 1C). At low EGF
concentrations, we observed transient FIRE accumulation dur-
ing the first 10–15 h, with homogeneous timing and amplitude.
When stimulated with EGF concentrations above 2.5 ng/ml,
cells showed a second phase of FIRE activity after about 15
h. This pattern of pathway activity was also reflected in the
mean response of all cells treated with a given dose of EGF,
which showed a first phase of reporter activity at about 10 h
for all conditions and a second phase of increasing amplitude
and duration for EGF concentrations above 2.5 ng/ml (Fig-
ure 1D). Our observations are consistent with feedback regula-
tion of the ERK pathway and EGF degradation, which is expo-
nential with a half-life of about 10 h for low EGF concentration
(Figure S1F). In contrast, EGF decays sub-exponentially and re-
mains elevated during the observed time period for higher EGF
concentrations, inducing the second signaling phase. On the
single-cell level, most cells showed a first FIRE response at
EGF concentrations as low as 1 ng/ml, whereas the fraction
of cells showing a second phase of FIRE signals saturated at
EGF concentrations of 5 ng/ml or higher (Figure 1E).
The Strength of Mitogenic Signaling Is Encoded by
Dynamic Features of Integrated ERK Activity
To better understand how individual cells encode the strength of
mitogenic stimuli, we defined characteristic features of FIRE dy-
namics and used information theory to determine the extent to
which they carry information about extracellular EGF concentra-
tions. Using themean responses to different EGF concentrations
as guides, we focused on the amplitude, fold change, timing of
the maximum, duration and area under the curve of the FIRE
signal separately for up to 15 h (first phase) as well as for the re-
maining time course after 20 h (second phase, Figure 2A). We
used mutual information as a measure of the interdependence
between these features and EGF concentration. More precisely,
we calculated mutual information between EGF concentrations
and individual as well as all pairwise combinations of these fea-
tures. Mutual information quantifies how much information one
variable conveys about the other variable. Therefore, it allows
us to quantify how much information about the extracellular
EGF concentration can be inferred from different features of
the FIRE response. We observed that the logarithmic fold
change during the first and second signaling phasewas the com-
bination with the highest mutual information, resulting in a value
of about 1.4 bits (Figure 2B). Mutual information of 1.4 bits indi-
cates that it is possible to infer approximately three levels of EGF
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Figure 1. ERK Activity in Living Cells
(A) Scheme of the EGF pathway, where EGFR stimulation triggers the activation of RAF, MEK, and ERK by phosphorylation. ERK translocates to the nucleus,
where it phosphorylates numerous targets, including the transcription factor FRA1. Phosphorylation of the PEST domain of FRA1 by ERK leads to stabilization of
the protein. We used a fluorescent reporter that contains the PEST domain of FRA1 and is stabilized by ERK phosphorylation (FIRE). See also Albeck et al. (2013).
(B) Example images of the FIRE reporter at indicated time points and EGF concentrations. Scale bar: 24 mm.
(C) Examples of single-cell FIRE reporter time series for randomly selected single cells treated with indicated EGF concentrations. Mean time courses (bold lines)
and standard deviations (gray ribbons) of all measured cells are indicated. Growth factor and serum-deprived cells were treated with the indicated doses of EGF.
Images were acquired every 20 min for 46 h.
(D) Average FIRE reporter time series for concentrations from 0 ng/ml EGF to 50 ng/ml EGF. Color indicates EGF concentration.
(E) Percentage of cells showing a response within 16 h (light gray) after stimulation and between 20 h after stimulation and the end of measurement (gray). Cells
with amplitudes greater than three standard deviations from the average of unstimulated cells were considered to be responding. Error bars indicate 95%
confidence interval based on bootstrapping (n = 1,000).
See also Figure S1.stimulation from the FIRE response. When inspecting the distri-
butions of these features for different EGF concentrations (Fig-
ures 2C and S2A), we noticed that both were very low for most
untreated cells, whereas stimulation with EGF resulted in loga-
rithmic fold changes of about 1.5 at early time points in most
cells. The logarithmic fold change for the second phase was
clearly different between low and high doses of EGF (Figures
2C and S2B), as stimulation with, for example, 1 ng/ml resulted
in fold changes below 1 in most cases, whereas stimulation
above 7.5 ng/ml resulted in much higher logarithmic fold
changes of 2–3. Therefore, the fold change of the first phase al-
lowed us to discriminate if the cells were stimulated and the fold
change of the second phase allowed us to discriminate betweenhigh and low dose (Figure 2D). When considering both first and
second phase, the response to three different concentrations
of EGF can be well separated (Figure 2D).
To determine if our focus on selected features of the dynamic
response restricted the information theoretical analysis of EGF
signaling, we clustered entire time series based on Euclidean
distance using the k-means algorithm (Figures S3A and S3B;
STAR Methods). However, mutual information calculated for
EGF concentrations and clusters of time series saturated at
about 1 bit, well below the 1.4 bits calculated for the most infor-
mative combination of features (Figure S3C). The information
content of individual time points of the FIRE measurements as
well as of immunofluorescent measurements of selectedCell Reports 31, 107514, April 14, 2020 3
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Figure 2. Bi-phasic ERK Activity Profiles
Encode External Ligand Concentration
(A) Scheme of features describing the FIRE
response after EGF treatment. The FIRE response
is separated into early and late responses, and
each phase is characterized by the following fea-
tures: amplitude (Amp), time of the maximum
(Time), fold change of the amplitude (FC), duration
of the response, and area under the curve (Auc), as
well as log2-scaled Amp and FC.
(B) Multivariate mutual information (top panel)
between EGF concentrations and FIRE features
(bottom panel, black: single features, gray: pair-
wise combinations). Features are sorted by their
median mutual information (top panel).
(C) Log2 FC of the amplitude for the first (left panel)
and second response (right panel) for indicated
EGF concentrations. Black lines indicate medians
of distributions; boxes include data between the
25th and 75th percentiles; whiskers extend to the
maximum values within 1.5 3 the interquartile
range; dots represent outliers.
(D) Contour plot of log2 FC for the first and second
response for indicated concentrations of EGF.
See also Figures S2 and S3.signaling-induced protein modifications at various time points
during the response was even more limited (Figures S3D–S3F).
Therefore, information-theoretical analysis is an elegant
tool to assess which features represent the input stimulus
most precisely. It suggests that three concentrations of EGF
are sufficient to sample and characterize the signaling response
in these cells.
ERK Activity Is Necessary but Not Sufficient for Cell
Cycle Entry and Progression
After identifying relevant dynamic features of integrated ERK ac-
tivity, we next aimed to characterize how EGF signaling controls
the phenotypic response of individual cells. To this end, we
determined if and when cells entered S phase by using a fusion
of the red fluorescent protein mCherry (RFP) with the first 110
amino acids of geminin (Albeck et al., 2013; Figure S4A). As gem-
inin is degraded by APCCdh1 during G1 and only accumulates
during S and G2 phases (Clijsters et al., 2013; Sakaue-Sawano
et al., 2008), we defined an increase of more than 2 3 the stan-
dard deviation of the basal RFP level as the time of S-phase entry
(Figure S4B). This method to determine S-phase entry correlated
well with measurements of actively replicating cells marked
by 5-ethynyl-2-deoxyuridine (EdU) incorporation, even at low
stimulation levels (Figures S4F–S4H). At the transition between
metaphase and anaphase of mitosis, geminin is degraded by
APCCdc20, which led to a sharp decline in the intensity of the
geminin reporter (Figure S4B). As the duration of mitosis, in gen-
eral, and of anaphase and telophase, specifically, is relatively
short given the duration of our observation period and the tem-
poral resolution of our experiments, we will refer to the duration
of geminin accumulation as the duration of S/G2 phase. More-
over, the beginning of geminin accumulation will be termed4 Cell Reports 31, 107514, April 14, 2020S-phase entry and the timing of the metaphase-to-anaphase
transition will be termed cell division.
Without EGF stimulation, cells showed neither S-phase entry
nor cell division, emphasizing that there was no residual mito-
genic activity under our experimental conditions and that all
observed cell cycle progression was dependent on EGF-
induced signaling. We found more and more cells entering S
phase when we increased the stimulus, reaching a maximum
of about 90% of the cells at concentrations of 7.5–10 ng/ml
EGF (Figure 3A). We observed a similar increase of cells dividing
at least once within 48 h, although the fraction of dividing cells
remained noticeably lower at around 70% (Figure 3A) as the
duration of S/G2 phase extended beyond the observation period
in cells with late S-phase entry. Accordingly, the time of S-phase
entry was heterogeneously distributed around 20 h post-stimu-
lation in individual cells, mostly independent of the strength of
the mitogenic stimulus (Figures 3B and S4C–S4E). A noticeable
exception were those cells that responded to very low EGF con-
centrations, as they only entered S phase at earlier time points,
which is consistent with a lack of signal at later times due to rapid
decay of EGF under these conditions. The duration of S/G2
phases was similarly distributed with a median around 18 h (Fig-
ure 3C). Interestingly, there was no clear correlation between
time of S-phase entry and duration of S/G2 phase (Figure 3D).
At low EGF concentrations, only about half of the cells entered
S phase (Figure 3A). Therefore, we asked if cells that entered S
phase differed in their integrated ERK activity profile, and thus
different signaling pathway engagement could be the reason
for the heterogeneity in cell cycle entry and progression. To
address this question, we calculated mutual information be-
tween individual and pairwise combinations of features of the
FIRE reporter time series and cell cycle states. However, even
A B C
D E
F
G
Figure 3. The Role of ERK Activity for Cell Cycle Entry and Progression
(A) Percentage of cells entering S phase (light gray) and dividing (dark gray) at indicated concentrations of EGF. Error bars indicate 95% confidence interval
estimated with bootstrapping (n = 1,000).
(B) Distribution of the time at which S phase starts after stimulation with indicated concentrations of EGF.
(legend continued on next page)
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the most informative feature combination provided only below
0.2 bits of mutual information (Figures 3E and S4J). Accordingly,
when analyzing cells that have been treated with 1 ng/ml EGF, a
concentration at which about 50% of the cells enter cell cycle,
the median FIRE signal during the first response was only slightly
higher in cells entering S phase than those that remained in G0/
G1 phase, emphasizing that the FIRE signal has a very low pre-
dictive power for the cell cycle fate of a cell (Figure 3F). Similarly,
actively replicating cells marked by EdU incorporation had only
slightly higher FIRE levels at various time points (Figure S4I). At
higher EGF concentrations, we also observed no noticeable dif-
ferences in the shape and amplitude between cells entering S
phase and those that did not (Figure 3F). Even when we align
the single-cell FIRE trajectories to the time of S-phase entry to
correct for asynchronies in the response and compared these
trajectories to FIRE trajectories of quiescent cells aligned to a
matched time distribution, we again detected only marginal dif-
ferences (Figure 3F).
As we could not observe a strong correlation between FIRE
levels and S-phase entry, we next analyzed if cell division was
influenced by integrated ERK activity. Comparing the fold
change in FIRE levels during the first response in dividing and
non-dividing cells, we observed a similar trend as for S-phase
entry (Figure 3G). Only when analyzing FIRE levels in the 16 h
preceding cell division did we observe a more noticeable differ-
ence between cycling and quiescent cells. However, as this dif-
ference was only visible when cells were stimulated with high
doses of EGF, the measurements did not provide support for a
decisive influence of ERK signaling in the completion of the cell
cycle. Most strikingly, integrated ERK activity was not elevated
at low doses of EGF in the hours before division, suggesting
that ERK activity might occur at late S phase when ligands are
present but may not be required to complete the cell cycle.
Taken together, our data corroborate that ERK activity is neces-
sary for quiescent cells to re-enter the cell cycle, as previously
reported (Sharrocks, 2006; Zhang and Liu, 2002), but they are
insufficient to explain the variability of cellular responses, arguing
for additional mitogenic inputs that are transmitted upon EGF
stimulation.
PI3K Signaling Contributes a Necessary Mitogenic
Stimulus upon EGF Treatment
To determine the extent to which the ERK/MAPK pathway
transmits pro-mitotic signal from EGFR signaling, we system-
atically perturbed EGFR and components of the MAPK
signaling pathway while monitoring integrated ERK activity,
time of S-phase entry, and duration of the S/G2 phase (Fig-(C) Estimates of the length of S/G2 phase distribution (time from beginning of S p
using Kaplan-Meier analysis.
(D) Scatterplot comparing the time at which S phase starts after stimulation and l
Ellipses indicate area that include 95% of the cells.
(E) Multivariate mutual information (top panel) between combinations of features o
indicates the theoretical maximum.
(F and G) Average (bold line) and standard deviation (ribbon) of reporter time series
that do not enter S phase (gray) stimulated with indicated concentrations of EGF
before the onset of S phase or equivalently sampled time series for non-respondin
the first 16.5 h after stimulation or before division (G).
See also Figure S4.
6 Cell Reports 31, 107514, April 14, 2020ure 4A). Blocking the activity of EGFR by using the small-mole-
cule inhibitor gefitinib abrogated all ERK signaling activity as
well as cell cycle entry and progression (Figures 4B and 4D),
reemphasizing that, in this model, EGFR signaling is absolutely
essential for cell cycle entry. Time-series measurements of
phosphoproteins showed that EGF stimulation activates
ERK, AKT, and JNK signaling (Figure 4C; Table S1). Inhibiting
the MAPK cascade with the MEK inhibitor AZD6244 led to a
strong reduction of phospho-ERK and induction of MEK phos-
phorylation (Figure 4C), consistent with feedback regulation
(Fritsche-Guenther et al., 2011; Klinger et al., 2013; Sturm
et al., 2010). Although MEK inhibition prevented FIRE activa-
tion to a similar extent as the EGFR inhibitor (Figure 4B), about
10% of cells started cycling in this condition (Figure 4D). Inter-
estingly, the duration of the S/G2 phase of those cells that
entered the cell cycle was unaffected by the MEK inhibitor
(Figure 4E).
Although pharmacological perturbation of the MAPK pathway
highlighted its importance for cell cycle progression, MEK inhibi-
tion did not lead to a complete block of S-phase entry, in contrast
to EGFR inhibition. This suggested that parallel pathways
contribute significantly to mitogenic signaling. Therefore, we
pharmacologically perturbed the interacting kinases p38
(SB203580), JNK (JNK inhibitor VI), and GSK3 (SB216763) as
well (Figures 4B–4E; Table S2). JNK and GSK3 inhibition had
no effect on ERK activity and led to only minor changes in the
cellular response (Figures 4B–4E). However, we observed a
marked increase in FIRE signals and MEK phosphorylation
upon p38 inhibition aswell as a reduction in AKT phosphorylation
(Figures 4B and 4E). Interestingly, this did not lead to an increase
in the fraction of cells entering S phase or dividing (Figure 4D). In
contrast, we observed a longer duration of the S/G2 phase as
well as a concomitant decrease in the number of cells dividing
(Figures 4D–4E). This, again, indicates that ERK activity is not
limiting for cell cycle regulation.
Finally, we inhibited the PI3K pathway by using pharmacolog-
ical inhibitors. As the PI3K pathway is activated in parallel to
MAPK signaling through the EGF receptor, it is an obvious candi-
date for transmitting additional mitogenic input. Indeed, inhibit-
ing PI3K itself by using the inhibitor LY29402 led to a near-com-
plete block of cell cycle entry and progression, and those few
cells that entered the cell cycle had prolonged S/G2 phases (Fig-
ures 4D and 4E). As with p38 inhibition, ERK was still as active as
in control cells, when assayed with the FIRE reporter (Figure 4B),
although phosphorylation was broadly reduced across path-
ways. The effect of inhibiting the downstream kinase AKT with
the small molecule MK-2206 was more restricted to thishase to division) for three different concentration of EGF (1, 7.5, and 50 ng/ml)
ength of S/G2 phase for two different concentrations of EGF (1 and 7.5 ng/ml).
f the FIRE reporter time series (as in Figure 2B) and cell cycle state. The red line
(normalized to unstimulated control) of cells entering S phase (yellow) and cells
. Left graphs show the first 16.5 h after stimulation; right graphs show 16.5 h
g cells (F). Comparison of dividing cells (orange) and non-dividing cells (gray) for
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Figure 4. Pharmacological Perturbation Reveals Relative Contributions of ERK and PI3K/AKT Pathways during Mitogenic Signaling
(A) Scheme of the EGF pathway indicating the targets (colored asterisk) of pharmacological inhibitors used in this study. Dashed lines indicate indirect activation.
(B) Average time courses of the FIRE reporter after stimulation with EGF for controls (gray) and after pre-incubation with the indicated inhibitors. For controls, the
standard deviation around the mean of five experiments is shown (gray ribbon).
(C) Effect of inhibitors on the phosphorylation state of targets in the MAPK and PI3K pathways. Changes in phosphorylation upon EGF stimulation (7.5 ng/ml) are
shown for indicated time points compared to unstimulated control (left, mean log2 FC, n = 2). The effect of inhibitors is shown compared to the respective
unperturbed time point after EGF stimulation (right). pS6, AKT substrate; pATF2, p38/JNK substrate. Significance of differences was tested using limma and
significant differences (p < 0.05) were indicated with an asterisk.
(D) Effect of inhibitors on the percentage of cells entering S phase (top panel) or dividing (bottom panel) at the indicated concentration of EGF. Error bars indicate
95% confidence interval based on bootstrapping (n = 1,000).
(E) Effect of inhibitors on the duration of S/G2 phases for two different EGF (1 and 7.5 ng/ml) concentrations by using Kaplan-Meier analysis.
See also Figures S5A and S5D.signaling branch when assayed on the level of phosphorylation
and led to similar effects on the cell cycle as PI3K inhibition
(Figures 4B–4F).Interestingly, we observed increased FIRE levels upon PI3K
and AKT inhibition. As blockage of PI3K, AKT, and p38 led to
reduced cell cycle entry and increased FIRE activity, it wasCell Reports 31, 107514, April 14, 2020 7
conceivable that inhibited cell cycle progressionmight feed back
into ERK signaling or might affect FIRE activity by different
means. To test this hypothesis, we inhibited cell cycle progres-
sion by using the CDK4/6 inhibitor palbociclib and the CDK1 in-
hibitor RO3306. Although these inhibitors prevented S-phase
entry and cell division, respectively, FIRE levels were not ampli-
fied, arguing against a direct influence of the cell cycle on ERK
activity (Figures S5A–S5D).
Cell Cycle Entry and Progression Have Diverging
Temporal Requirements for MAPK and PI3K Signaling
To gain a better understanding of the relative contribution of
MAPK and PI3K signaling for regulating cell cycle entry and pro-
gression, we inhibited the corresponding pathways as well as
EGFR activity at different time points during the first 20 h after
growth factor stimulation (Figure 5A). When EGFR-dependent
signaling was blocked entirely 10 h after EGF treatment by using
the receptor inhibitor gefitinib, FIRE signals rapidly decayed and
cell cycle entry was prevented in almost all cells (Figures 5B–5E).
Sustaining EGFR activity for 15 or 20 h led to an increasing frac-
tion of cells entering and progressing through the cell cycle. As
expected, the duration of ERK activity was extended as well.
We observed a similar abrogation of the FIRE response when
we blocked the MAPK pathway at the level of MEK at different
time points after EGF stimulation (Figure 5B; Gillies et al.,
2017). However, more cells entered S phase when the MEK in-
hibitor was added at 10 h than gefitinib. Even more striking
was the relative increase in cells dividing compared with EGFR
inhibition at all time points tested (Figure 5C). In contrast, block-
ing PI3K signaling at 10, 15, or 20 h post-EGF treatment led to a
comparable or even stronger suppression of S-phase entry and
cell division as EGFR inhibition despite only temporarily attenu-
ating ERK activity (Figures 5B and 5C). Inhibiting EGFR, MEK,
or PI3K for different periods at the beginning of the experiment
led to delayed FIRE accumulation and S-phase entry, as ex-
pected (Figures S5E, S5H, S5G, and S5J). However, cells still
entered S phase in comparable numbers after inhibitors were
washed away (Figures S5F and S5I). Only when inhibitors were
applied for 15 h did the number of dividing cells decrease due
to the limited observation period. These experiments corrobo-
rate that both ERK and PI3K activity are necessary for S-phase
entry (Jones and Kazlauskas, 2001).
When we examined cells that progressed into S phase upon
PI3K inhibition more closely, we noticed higher geminin levels at
the time of treatment, indicating that they already passed the re-
striction point and initiated the transition from G1 to S phase prior
to the loss of PI3K activity (Figure 5D). Importantly, we observed
strongly increased durations of the S/G2 phase in cycling cell
whenweblockedPI3Ksignaling 10–20h after EGF treatment (Fig-
ure 5E). The same decreased rate of cell cycle progression was
observed upon EGFR inhibition, whereas preventing ERK activa-
tion had no effect once cells entered the cell cycle (Figure 5E).
To further study the important role of PI3K signaling for S- and
G2-phase progression, we aimed to initiate ERK activity for a
short period and then additionally activate PI3K by additional li-
gands. To do so, we used EGF at very low doses (0.1–0.5 ng/ml)
that, due to ligand degradation, are expected to signal only tran-
siently. We additionally stimulated cells with insulin-like growth8 Cell Reports 31, 107514, April 14, 2020factor (IGF), which preferentially activates AKT (Figure 6A).
When assessing signaling activity by measuring phosphopro-
teins after stimulation with a high or low dose of EGF and a com-
bination of low dose EGF and IGF, we confirmed that a low dose
of EGF led to transient activation of many phosphoproteins,
which peaked at 5 h (Figure 6B; Table S3). The addition of IGF
induced increased phosphorylation of AKT and further down-
stream targets of PI3K, such as S6 or mTOR, throughout the first
24 h, while leaving other modifications unaltered. Using the FIRE
reporter, we confirmed transient ERK activation at low doses of
EGF that was unaffected by the addition of IGF (Figures 6C and
S6C). Moreover, IGF treatment alone did not induce FIRE accu-
mulation (Figure S6A). Although the transient input by EGF was
sufficient to induce cell cycle entry in about 25% of cells (Figures
6D and S6D), these cells needed longer to complete S/G2 phase
than cells with high EGF inputs (Figures 6E and S6E). However,
when we combined low EGF input with IGF stimulation, which
predominantly activates the PI3K pathway, it rescued the pheno-
type and resulted in cell cycle progression rates comparable to
high EGF stimuli (Figures 6E and S6E). Importantly, IGF treat-
ment alone did not result in appreciable cell cycle entry (Fig-
ure S6B), whereas a combination of low EGF and strong IGF in-
puts led to a modest increase in the fraction of cells entering S
phase and dividing (Figures 6D and S6D). Consistently,
actively replicating cells incorporating EdU showed a trend to-
ward higher levels of phosphorylated AKT than those cells re-
maining in G1 upon treatment with both EGF alone and EGF
together with IGF (Figures S6F and S6G). We obtained similar re-
sults when combining EGF at a low dose with insulin (Figures
S6H–S6J).
To investigate the role of PI3K signaling during S and G2
phase, we stimulated cells with EGF and inhibited MEK and
PI3K activity 15 h later. We then used single-cell RNA
sequencing (scRNA-seq) to determine expression profiles of in-
dividual cells 20 h and 30 h after the addition of the growth factor
(Figure 7A; STARMethods). Visualization of the resulting data by
dimensionality reduction using uniform manifold approximation
and projection (UMAP) showed clear separation of quiescent
and EGF-stimulated cells (Figure 7B, gray and blue dots). Inhib-
iting PI3K and, to a lesser extent, MEK led to distinct expression
profiles that clustered separately from cells treated with EGF
only (Figure 7B, green and red dots). Interestingly, expression
profiles of inhibitor-treated cells differed at the 20-h and 30
h-time points. Similar results were obtained in a replicate exper-
iment and by using a different dimensionality reduction method
(principal-component analysis, Figures S7A and S7B). To corre-
late expression profiles of individual cells with cell cycle progres-
sion, we mapped the cell cycle state of each cell by using char-
acterizedmarker genes (Stuart et al., 2019; STARMethods). This
allowed us to determine cell cycle distributions for each condi-
tion and time point that were comparable to previous analysis
using time-lapse microscopy (Figure S7C). Combining the
UMAP projection with cell cycle information revealed a clear pro-
gression of EGF-stimulated cells from G1 to S and G2/M phase
(compare Figures 7B and C). Importantly, cells progressing into
S and G2/M phase in the presence of PI3K and MEK inhibitors
showed clearly distinguishable expression profiles. Using the
pathway activity scores calculated by the PROGENy method
A B
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Figure 5. Temporal Requirements for ERK and AKT Activity Differ during Cell Cycle Progression
(A) Scheme of experiment. EGFR, MEK, and PI3K inhibitors were added either at time of stimulation or 10, 15, or 20 h after stimulation.
(B) Average time courses of the FIRE reporter after stimulation with 7.5 ng/ml EGF and incubation with the indicated pharmacological inhibitors at different time
points or controls (gray). For controls, the standard deviation around the mean of three experiments is shown (gray ribbon).
(C) Effect of inhibitors on the percentage of cells entering S phase (left) or dividing (right) for the indicated time of inhibition after stimulation. Error bars indicate
95% confidence interval based on bootstrapping (n = 1,000).
(D) Comparison of geminin levels at time of inhibitor treatment (as indicated) between cells entering S phase (right, dark gray) and cells that do not enter S phase
(left, light gray) within the time of measurement. Numbers of cells for each condition are indicated.
(E) Effect of the time of inhibitor treatment (as indicated) on the duration of S/G2 phases after stimulation with 7.5 ng/ml EGF compared to controls using Kaplan-
Meier analysis.
See also Figures S5E–S5J.(Schubert et al., 2018), we validated that inhibitor treatment led
to the expected changes in MAPK and PI3K signaling (Fig-
ure S7D). Next, we determined differentially expressed genes
upon inhibitor treatment depending on cell cycle state and
time point and resolved the corresponding molecular pathways
using Gene Ontology (GO) term analysis (Figure S7E). In G1-
phase cells, we mainly observed changes in the expected mo-
lecular pathways, such as response to growth factors. InS-phase cells, only PI3K-inhibitor -treated cells showed signifi-
cant changes, whichmainly affected pathways involved in meta-
bolic processes, such as mitochondrial respiration, translation,
and ribonucleotide synthesis. In G2/M-phase cells at 30-h
post-EGF stimulation, MEK and PI3K inhibition induced distinct
alterations in pathway activity. For PI3K inhibition, changes in
G2/M-phase cells partially overlapped with those observed dur-
ing S phase.Cell Reports 31, 107514, April 14, 2020 9
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Figure 6. AKT Activation Rescued Delayed Cell Cycle Progression at Low EGF Concentrations
(A) Pathway scheme of the EGF and IGF pathways and overview of the performed rescue experiment.
(B) Effect of low and high doses of EGF stimulation (0.5 ng/ml and 50 ng/ml) as well as IGF co-stimulation on the phosphorylation state of targets in the MAPK and
PI3K pathway. Changes in phosphorylation are shown for four time points compared to unstimulated control (mean log2 FC, n = 2). p-mTOR, BAD-AKT sub-
strates; pSTAT3, pP90RSK-ERK substrates
(C) Average time courses of the FIRE reporter after stimulation with different concentrations of EGF as well as co-stimulation with IGF.
(D) Percentage of cells entering S phase (solid bars) or dividing (open bars) after stimulation. Error bars indicate 95% confidence interval based on bootstrapping
(n = 1,000).
(E) Duration of S/G2 phase using Kaplan-Meier analysis.
See also Figure S6.To determine whether the observed delay in cell cycle pro-
gression upon PI3K inhibition was due to an increased duration
of S or G2/M phase, we further analyzed cell cycle distributions
from scRNA-seq. As expected, we observed a decreased frac-
tion of cells in S, G2, or M phase 20 h after EGF treatment
when MEK or PI3K activity was inhibited 15-h post-stimulation
(Figure 7D, top graph). The fraction of S/G2M-phase cells further
decreased at the 30-h time point, as no additional cells could
enter S phase in the absence of MAPK or PI3K activity, whereas
others successfully progressed through the cell cycle and
divided. When we analyzed the ratio between S- and G2/M-
phase cells under both conditions, we observed that most
MEK-inhibitor-treated cells completed S phase between the
20-h and 30-h time point (Figure 7D, bottom graph). However,
upon PI3K inhibition, a noticeable fraction of cells remained in10 Cell Reports 31, 107514, April 14, 2020S phase at the 30-h time point, indicating a delay in S-phase
progression.
To support this conclusion, we monitored FIRE reporter cells
upon EGF treatment by time-lapse microscopy, inhibited MEK
and PI3K activity after 15 h, and performed metabolic labeling
with EdU at 22.5-h and 32.5-h post-stimulation, respectively (Fig-
ure 7E). Consistent with our scRNA-seq analysis, we observed
that most geminin-positive cells were actively replicating at the
22.5-h time point (Figure 7F). After 32.5 h, MEK-inhibitor-treated
cells completed S phase and entered G2 phase. Under control
conditions, we still observed some replicating cells at this time
point, as cells were still able to enter S phase from G1. However,
although no additional cells were able to enter S phase upon
PI3K inhibition, we observed that most treated cells still incorpo-
rated EdU at the later time point. To estimate the corresponding
A B C D
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Figure 7. PI3K Signaling Is Required for Timely Progression through S Phase
(A) Scheme of single-cell RNA sequencing experiments. Cells were stimulated with 7.5 ng/ml EGF. MEK or PI3K inhibitors were added after 15 h and cells were
sampled for single-cell RNA sequencing at the indicated time points.
(B) UMAP for one experiment. Cells are barcoded for experimental condition.
(C) UMAP as in (B) with cells barcoded for cell cycle phases.
(D) Percentage of cells in S/G2M phase (top panel) based on cell cycle markers (dots, replicates; lines, mean). Effect of MEK or PI3K inhibitors, respectively, on
percentage of cells in S phase (bottom panel).
(E) Scheme of live-cell imaging experiments with EdU stainings at different time points.
(F) Percent of EdU-positive cells that started S phase before EdU staining based on analysis of geminin levels. Error bars indicate 95% confidence interval based
on bootstrapping (n = 1,000).
(G) Effect of MEK or PI3K inhibitor on the number of EdU-positive cells labeled at indicated time points. Cells were binned according to the time since entering S
phase (based on geminin). Error bars indicate 95% confidence interval based on bootstrapping (n = 1,000).
(H) Effect of MEK (orange) and PI3K inhibitor (green) on the extent of EdU incorporation.
See also Figure S7.time of S-phase progression, we binned cells according to the
time of S-phase entry, as indicated by geminin accumulation rela-
tive to the time of metabolic labeling, and determined the corre-
sponding fraction of EdU-positive cells (Figure 7G). Although con-
trol and MEK-inhibitor-treated cells completed S phase within 16
h, most cells remained in S phase for over 20 h in the absence of
PI3Kactivity. This severedelay inS-phaseprogressionwas further
supported by a slower rate of EdU label incorporation in PI3Ki-
than in MEK-inhibitor-treated cells (Figure 7H).
Taken together, quantitative time-resolved analysis at the sin-
gle-cell level showed that the mitogenic input of EGF ligands istransmitted both by theMAPK and PI3K signaling pathway. Acti-
vation of both pathways together is necessary for cell cycle en-
try. However, timely progression through S phase depends on
sustained PI3K signaling to adjust the metabolism of the cell to
the replicative state.
DISCUSSION
Mitogenic signaling allows multicellular organisms to regulate
the rate and timing of cell division. To ensure precise control
over cell cycle entry and progression, the information flowCell Reports 31, 107514, April 14, 2020 11
through multiple signaling pathways needs to be integrated
dynamically to coordinate the different components of the
cell cycle machinery (Chambard et al., 2007). Combining
time-resolved measurements in individual cells with com-
puter-aided data analysis, information theoretical calcula-
tions and pharmacological perturbations allowed us to
disentangle the contributions of the MAPK and PI3K/AKT
pathways to mitogenic signaling during different phases of
the cell cycle.
To measure signaling activity, we used live-cell microscopy of
fluorescent reporter cells. In addition to unrivaled temporal reso-
lution, live-cell microscopy allows resolving non-genetic hetero-
geneity that can strongly influence the outcome of signaling
events (Spiller et al., 2010). Several strategies have been devel-
oped to monitor MAPK pathway activity in living cells: FRET-
based reporters allow direct measurements of substrate phos-
phorylation but are limited by a low signal-to-noise ratio and
are prone to saturation (Gillies et al., 2017; Komatsu et al.,
2011; Ryu et al., 2015; Selimkhanov et al., 2014). Transloca-
tion-based reporters provide a similar but more robust ratio-
metric measure (Regot et al., 2014). However, their sensitivity
is also restricted to certain segments of the ERK dynamic range
(Gillies et al., 2017). Nuclear localization of an ERK-yellow fluo-
rescent protein (YFP) fusion correlates with its activity on short
timescales but can be affected by other cellular processes (Co-
hen-Saidon et al., 2009). Finally, as we were interested in under-
standing how andwhen total ERK activity affected cell cycle pro-
gression, we decided to use the FIRE reporter that linearly
reflects integrated ERK activity (Albeck et al., 2013; Gillies
et al., 2017). Although the FIRE reporter does not allow us to
directly follow the short-term dynamics of ERK activity observed
with other reporters, it provides a robust readout that enabled us
to faithfully measure the contribution of MAPK signaling over the
long timescales involved in progressing from a quiescent state to
cell division. When comparing our measurements to previously
reported data from Albeck et al. (2013), it is important to keep
in mind that different experimental conditions were used.
Although previous studies focused on steady-state EGF
signaling under sustained stimulations, we investigated the
response of quiescent cells to acute growth factor stimulation.
Also, as the FIRE reporter captures only nuclear activity, we
could not consider signaling effects of the MAPK pathway that
take place in the cytoplasm (Murphy et al., 2002). This might
explain why under some conditions, such as PI3K and AKT inhi-
bition, FIRE response and phosphorylation diverge. Further-
more, the use of a synthetic reporter such as FIREmay introduce
additional variability that could potentially degrade measure-
ments of information flow and mask correlations in individual
cells. As an alternative, measurements of endogenously tagged
ERK targets, such as FRA1, may be used (Gillies et al., 2017).
Using automated image analysis, we extracted a time series of
ERK activity over 2 days for thousands of cells treated with
various concentrations of EGF. Information theoretical calcula-
tions allowed us to identify the features of the dynamic ERK
response that conveyed themost information about extracellular
EGF concentrations. In recent years, information theory has
been increasingly used to investigate principles of signal trans-
duction or to quantitatively compare signaling pathways12 Cell Reports 31, 107514, April 14, 2020(Brennan et al., 2012; Mc Mahon et al., 2014). Analysis of tumor
necrosis factor alpha (TNFa)-induced nuclear factor kB (NF-kB)
signaling at a single time point, for example, indicated that
information transmission through the network is restricted by
molecular noise and, therefore, limits the ability of a cell to derive
precise information about ligand concentrations (mutual infor-
mation, <1 bit) (Cheong et al., 2011). Similar low capacities to
transmit information were observed for other pathways,
including calcium, cyclic AMP (cAMP), and MAPK signaling
(Garner et al., 2016; Selimkhanov et al., 2014; Uda et al., 2013;
Voliotis et al., 2014). However, estimating information flow from
a limited number of measurements at arbitrarily selected points
of the underlying molecular networks has its limitations. For
example, restrictions on information transmission can be miti-
gated by integrating temporal information or modulating feed-
back strength (Garner et al., 2016; Voliotis et al., 2014).
Our analysis confirms that when considering appropriate dy-
namic features, mutual information above 1 bit can be obtained.
We used information theory to systematically probe which fea-
tures of the reporter time series carry the most information.
This analysis showed that the combination of fold changes of
the first and second response of the biphasic ERK activity profile
convey the most information about extracellular ligand concen-
tration. Our continuous measurements from unperturbed indi-
vidual cells, thus, confirmed previous observations from
biochemical studies of cell populations (Meloche et al., 1992).
From these data, it was proposed that initial ERK activity is
necessary to mediate the transition from the G0 state of the
cell cycle to G1. During G1 phase, reduced nuclear ERK activity
promotes cell cycle progression, as the transcription factor FOS
is degraded and replaced by FRA1 (Burch et al., 2004). Suffi-
ciently strong activation of ERK during late G1 phase is finally
necessary to induce transcription factors, such as EGR1, which
mediate the all-or-none decision to enter S phase and divide
(Zwang et al., 2011). Using pharmacological inhibitors to artifi-
cially abbreviate ERK activity, we could confirm that some level
of ERK signaling is required for S-phase entry (Figure 5). How-
ever, we did not detect a clear correlation between ERK activity
and S-phase entry at low EGF doses in simultaneous measure-
ments of FIRE and cell cycle reporters (Figure 3F). Consistently,
there was no direct correlation between S-phase entry and the
occurrence of a second signaling phase (Figures 1E and 3A).
We, therefore, hypothesize that entering S phase is similar to a
stochastic decision that requires sustained ERK activity. De-
pending on the duration of G1 phase, transient ERK signaling
may suffice in one cell, whereas both phases of ERK signaling
may be required in another one. A corresponding threshold
mechanism could be based on EGR1 induction and convert
the graded input of ERK activation into a digital decision to
pass the restriction point (Zwang et al., 2011) .
The observed heterogeneity in S-phase entry may be due to
varying levels of cell cycle inhibitors, such as p21. In elegant sin-
gle-cell experiments, it was shown that the decision between
proliferation and quiescence in cycling MCF10A cells is
controlled by a bifurcation in CDK2 activity due to varying levels
of p21 as a consequence of endogenous DNA damage during
replication (Arora et al., 2017; Barr et al., 2017; Spencer et al.,
2013). It will now be interesting to investigate if heterogeneity
in p21 persists during growth-factor-starvation-induced quies-
cence or if other molecular mechanisms are involved in the
observed heterogeneous responses to low EGF concentrations.
For example, it is conceivable that heterogeneous expression of
inhibitors of the PI3K pathway, which we showed to be required
for cell cycle entry as well, contributes to the proliferation-quies-
cence decision.
In addition to quantifying the decision to enter cell cycle, we
followed the phenotypic response of each cell to determine the
frequency and timing of cell division. By integrating molecular
measurements of post-translational modifications as well as
pharmacological perturbations, we showed that ERK signaling
is dispensable after crossing of the restriction point, whereas
PI3K/AKT activity was necessary both for entering S phase and
for timely progression to mitosis. However, activation of AKT
through IGF or insulin alone was insufficient to induce cell cycle
entry. During G1, it is known that ERK and AKT signaling interact
at the level of cell cycle inhibitors, although the precise effects
may depend on the cell line studied (Worster et al., 2012; Zwang
et al., 2011). Our data from pharmacological inhibition at different
intervals after stimulation show that after PI3K inhibition, no
further cells enter S phase, whereas with MEK inhibition, some
cells still enter S phase. This is consistent with previous studies,
which showed that progression through G1 requires PI3K/AKT
and ERK signaling, whereas S-phase entry itself is mainly depen-
dent on PI3K/AKT (Jones and Kazlauskas, 2001). As AKT activity
can suppress anti-proliferative gene products induced during
early G1 phase, it may render cells permissive for ERK-driven
S-phase entry (Zwang et al., 2011). AKT’s role in controlling pro-
gression through S/G2 phase is less well documented. It was
shown that blocking PI3K/AKT signaling prolongs progression
through S/G2, although it remained unclear if S phase or G2
phase is prolonged (Dangi et al., 2003). Our data from scRNA-
seq and life-cell imaging combined with metabolic labeling
show that inhibition of AKT signaling strongly prolongs S phase.
One proposed mechanism is that AKT phosphorylates CDK2
and regulates its subcellular localization during S phase (Maddika
et al., 2008). The resulting AKT-induced nucleo-cytoplasmic shut-
tling of CDK2 may be necessary for cell cycle progression. In
further studies, it may be interesting to measure AKT activity
and CDK2 localization simultaneously in living cells. Additionally,
metabolic demands of S phase may require high AKT signaling.
The AKT signaling pathway is a key regulator of cellular meta-
bolism, including glycolysis and nucleotide biosynthesis (Ward
and Thompson, 2012). Analysis of the differentially expressed
genes in our scRNA-seq data showed that, indeed, PI3K
blockagederegulates genes involved inmetabolic processesdur-
ing S phase. This provides evidence that unmet metabolic de-
mand might contribute to prolonged S-phase progression in the
absence of AKT signaling. In addition, AKT signaling also influ-
ences cell growth by mTOR signaling (Ward and Thompson,
2012), and cell size, in turn, might influence the length of S phase
(Lloyd, 2013). However, it is currently unknown if and how cell size
and cell cycle are coupled (Lloyd, 2013).
Perturbations of the signaling processes controlling cell
cycle progression can be involved in severe pathologies. Ampli-
fication of EGF receptors in breast cancer cells, for example, in-
crease mitogenic input to both ERK and PI3K/AKT signalingpathways. Alterations in the E2F/Rb system or loss of cell cycle
inhibitors renders cells more permissive to ERK signaling. Muta-
tions in the PI3K pathway, such as PTEN deletion, lead to
increased AKT activity. Although single perturbations will not
lead to changes in cell proliferation in most cases, the accumu-
lation of alterations observed during tumorigenesis increase
information flow through both mitogenic pathways and cause
hypersensitivity to growth factors. Conversely, a detailed under-
standing of temporal requirements for and synergies between
major mitogenic mechanismsmay enable us to devise therapeu-
tic interventions that counteract altered cell signaling. Rationally
designed schedules of combination therapies may provide more
efficiency in targeting both cycling and quiescent cells than
continuous treatment with single agents, such as gefitinib.
Further studies combining quantitative experimental data with
computer-aided analysis will provide the necessary molecular
insights for such next-generation therapies.
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Chromium Single Cell B Chip Kit 10x Genomics PN-1000073
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BD Single-Cell Multiplexing Kit—Human BD Biosciences 633781
Deposited Data
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Single cell time series This study https://dx.doi.org/10.25534/tudatalib-158
Analysis code This study https://dx.doi.org/10.25534/tudatalib-160
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ImageJ https://imagej.net/ImageJ Version 1.8; RRID:SCR_003070
R https://www.r-project.org Version 3.6; RRID;SCR_001905
MATLAB Mathworks R2016b; RRID:SCR_001622
Python https://www.python.org/ Version 3.7; RRID:SCR_008394
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Inverted fluorescence microscope Nikon Ti-E inverted
m-Plate 24 Well Black ibidi Cat#82406LEAD CONTACT AND MATERIALS AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to andwill be fulfilled by the LeadContact, Alexander
Loewer (loewer@bio.tu-darmstadt.de).
Materials Availability
This study did not generate new unique reagents.
Data and Code Availability
Time series data of all tracked cells (https://doi.org/10.25534/tudatalib-158) as well as data analysis scripts (https://doi.org/10.
25534/tudatalib-160) are available online. ScRNA-seq data is available at GEO under the accession number GSE147259 (https://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147259). Original image data and image analysis scripts are available from
the corresponding author upon reasonable request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines
MCF10A cells were grown in DMEM/F12 medium supplemented with 5% horse serum (Thermo Fisher), 20 ng/ml EGF (PeptroTech),
0.5 mg/ml hydrocortisone, 100 ng/ml cholera toxin, 10 mg/ml insulin (all Sigma), penicillin-streptomycin and 13GlutaxMaxTM (Thermo
Fisher). The FIRE reporter has been previously described (Albeck et al., 2013) . In brief, it is an indirect reporter of ERK activity, which
consists of the PEST domain of FRA1 fused to YFP. Expression is driven by the MSCV LTR (murine stem cell virus long terminal
repeat). The reporter cell line also stably expresses NLS-CFP (mCerulian) as a nuclear marker to facilitate automatically tracking
and segmenting cells. In addition, the reporter cell line also expresses GMNN as a marker for the transition from G1- into S-phase
and for division.
METHOD DETAILS
Luminex assays
We seeded 37,500 cells per well in a 24-well plate and let them grow for 48 h in complete growthmedium (see above). Afterward, cells
were growth factor-starved for 48 h and stimulated with either 1 ng/ml or 7.5 ng/ml EGF for different durations (0 h, 1 h, 2.5 h, 5 h and
24 h). Thirty minutes prior EGF stimulation, cells were treated with inhibitors against MEK (1 uM), GSK3 (10 uM), JNK (10 uM), p38 (1
uM), AKT (1 uM) and PI3K (50 uM). Lysates were prepared according to the supplier’s protocol and analyzed with the Bio-Plex Protein
Array system (Bio-Rad, Hercules, CA) using beads specific for pAKT (S473), pERK1/2 (T202/Y204, T185/Y187), pMEK1 (S217/S221),
pRPS6 (S235/236), pATF2 (T71), pSTAT3 (Tyr705), pP90RSK (Ser380), pP38 (Thr180/Tyr182), p-mTOR (Ser2448), pJNK (Thr183/
Tyr185), pGSK-3a/b (Ser21/Ser9) and pBAD (Ser136). For data acquisition, the Bio-Plex Manager software was used. The raw
data was further analyzed using customized R-scripts.
Extracellular EGF concentrations in combination with a standard weremeasured in cell culture supernatants using the Bio-Plex Pro
Human Cancer Biomarker 2 panel (Bio-Rad) according to the manufacturer’s recommendations.
Live-cell microscopy experiments
For live-cell imaging experiments, we used 24-well imaging plates (ibidi). We seeded 37,500 cells per well and incubated them
in normal medium for 36 h before a 48 h starvation period in DMEM/F12 containing 0.3% tissue culture grade BSA (Sigma),Cell Reports 31, 107514, April 14, 2020 e2
0.5 mg/ml hydrocortisone, 100 ng/ml cholera toxin, penicillin, and streptomycin. At least 2 h before the experiment we changed me-
dium to phenol red – free FluoroBrite medium (Thermo Fisher) containing 0.3% tissue culture grade BSA (Sigma), 0.5 mg/ml hydro-
cortisone, 100 ng/ml cholera toxin, 13 glutamax, 10 mM HEPES, penicillin and streptomycin. In stimulation experiments, cells were
tracked for an hour prior to EGF addition. Cells were imaged on a Nikon Ti inverted microscope enclosed with an environmental
chamber controlling temperature, atmosphere (5% CO2), and humidity using a 20 3 Plan Apo objective (NA 0.75) and a Nikon
Qi2 camera. Cells were imaged every 20 min for up to 48 h.
EdU staining
For EdU staining in live-cell imaging, cells were incubated with 10 mM EdU (EdU Click-647) at defined time points. After 40 min, EdU
was washed off with medium and the supernatant of a backup plate, which was treated equally, was utilized to ensure appropriate
EGF concentrations. Immediately after the experiment, cells were fixedwith 2%paraformaldehyde, washedwith PBS, permeabilized
with 0.1% Triton X-100/PBS and blocked with 10% goat serum/PBS. For EdU detection, a reaction cocktail was prepared according
to the manufacturer’s instructions and added to the cells. After 30min incubation at room temperature, cells were washed and coun-
terstained with 2 mg/ml Hoechst in 0.1% Triton X-100/PBS. Using the same positions, cells were imaged for one additional loop in the
microscope and correlated with the previous captured images.
Immunofluorescence
Cells were seeded and treated equally to the live-cell microscopy experiments. After a 48-hour growth factor starvation, cells were
stimulated with EGF at specific time points to fix all conditions with 2% paraformaldehyde simultaneously. After permeabilizing with
0.1% Triton X-100/PBS, cells were blocked with 10% goat serum/PBS and incubated with primary antibodies in 1% BSA/PBS.
Washing steps using 0.1% Triton X-100/PBS and following incubation with secondary antibodies conjugated with Alexa Fluor 488
(#A-11034) and Alexa Fluor 647 (#A-21245, Thermo Fisher Scientific) in 1% BSA/PBS were performed. After further washing steps,
cells were stained with 2 mg/ml Hoechst in 0.1% Triton X-100/PBS. Stored in PBS, images were acquired with a 203 plan apo objec-
tive (NA 0.75) using appropriate filter sets. Automated segmentation was performed in MATLAB (MathWorks) with algorithms from
CellProfiler (Carpenter et al., 2006).
Single cell preparation for scRNA sequencing
For scRNA sequencing, 6-cm plates were used with 4.3 3 105 cells per plate and treated equally to the live-cell microscopy exper-
iments. After a 48-hour growth factor starvation, cells were stimulated with EGF at specific time points to trypsinize them simulta-
neously and adjusted the cell number to 500.000 cells per condition. Each sample was resuspended in 50 ml BD Stain Buffer
(FBS) and labeled with a specific Sample Tag (10 ml) for 20 min at room temperature. After adding 100 ml BD Stain Buffer, cells
were mixed, centrifuged and washed with 500 ml BD Stain Buffer. Using 500 ml RNase free PBS, all cells were pooled in a single
tube and counted to ensure a sufficient cell number. After centrifugation and resuspension in RNase free PBS, pre-chilled methanol
was added dropwise to the sample while mildly vortexing. Cells were kept on ice for 15 min, mixed, divided into 1 mL aliquots and
stored at 80C.
Rehydration and library preparation
Rehydration was done at 4C; cells were pelleted and washed twice in rehydration buffer (DPBS, 10%BSA, 0.5U/ml RNase Inhibitor),
then filtered and counted. The 30 RNA library war prepared according to the ‘‘Chromium Single Cell 30 Reagent Kits v3’’-protocol
(CG000183 Rev A) with a targeted cell recovery of 10.000 cells. At step 2.3.d of cDNA Cleanup the supernatant was removed and
used for sample tag library preparation according to the ‘‘BD Single-Cell Multiplexing Kit—Human’’-protocol (Reagent Kit v2, Doc
ID: 179682 Rev. 1.0). The cDNA library was complemented with 5% of its corresponding sample tag library to be run in the same
sequencing run. Samples were sequenced on an Illumina HiSeq 4000 sequencer.
QUANTIFICATION AND STATISTICAL ANALYSIS
Single cell RNA sequencing analysis
Readmapping and countingwas done using cellranger version 3.0.2 using a dual genome reference consisting of the human genome
GRCh38 as supplied by cell ranger, and an artificial genome containing the BD sequence tags. Demultiplexing was done using a
custom script that reads the BAM file and counts sequences that map to the artificial BD sequence tags genome, and removes dupli-
cate UMIs per cell. Subsequently, cells were assigned to samples (or duplets) using the HTODemux() function of Seurat (Stuart et al.,
2019) after normalization (as described in the Seurat manual). Transcriptome analysis of the single cell RNA sequencing samples was
done using Seurat (Stuart et al., 2019). In brief, low quality cells were removed based on mitochondrial contamination and number of
unique genes. Each gene was normalized by the total expression in the cell, scaled by 10,000 and log-transformed. Cell cycle status
was defined using a list of cell cycle markers from Tirosh et al. (2016) as provided by Seurat. For differential gene expression
analysis, cells were grouped by experiment, condition, and cell cycle phase to generate pseudo-bulk samples. Differential gene
expression analysis was done using DESeq2 (Love et al., 2014). To identify the effect of inhibitors on pathway activity, we used vari-
ance-stabilized data as provided by DESeq2 and applied PROGENy (Schubert et al., 2018) . The differentially expressed genes in thee3 Cell Reports 31, 107514, April 14, 2020
pseudo-bulk samples were further analyzed using GO enrichment (R package: clusterProfiler; Yu et al., 2012). The identified GO-
terms were simplified using a semantic similarity measure, which depends on the frequencies of two GO terms involved and that
of their closest common ancestor term (R package: GOSemSim; Yu et al., 2010).
Data analysis of live-cell experiments
Cells were tracked throughout the duration of the experiment using custom-written MATLAB (MathWorks, Natick, MA) scripts based
on code developed by the Alon lab (Cohen et al., 2008) and the Cell Profiler project (Carpenter et al., 2006) as previously described
(Strasen et al., 2018). In brief, we applied flat-field correction and background subtraction to raw images before segmenting individual
nuclei from images of the NLS-CFP reporter using adaptive thresholding and seeded watershed algorithms. Segmented cells were
assigned to corresponding cells in subsequent images using a greedy match algorithm based on a cost function, which included the
velocity and direction of movement for a cell. Additionally, the fluorescence intensity of the nuclear marker was used to ensure con-
sistency. We then quantified the nuclear fluorescence intensity of the FIRE reporter for each cell over time and normalized the result-
ing single-cell trajectories by dividing with the nuclear fluorescence of the NLS-CFP reporter to account for changes in nuclear shape.
This normalization eliminated spurious peaks and disturbances by cell division. The measurements of unstimulated control cells
included in each experiment were used for further normalization resulting in a fold-change of FIRE levels compared to unstimulated
means (Figure S1E). Specifically, for each cell the FIRE levels at each time-point were divided mean FIRE level of the unstimulated
control at that time-point. Cells with an amplitude greater than three standard deviations from the average amplitude of
unstimulated cells are considered to be responders.
To identify cell cycle states using Geminin, we first normalize the time courses by themean of the unstimulated control. Time points
with a Geminin response smaller than a threshold (mean + 2*sd of unstimulated control) are defined as part of the G1-phase, when
Geminin is not expressed (Figure S4B). Using run-length encoding, we can identify the duration of S/G2-phase and the time point of
division. To avoid false positive detection cell cycle phases, we include only cells in our analysis, where the time between beginning of
S-phase and division is at least 4 h.
Percent of dividing cells was used to compare effects between different concentrations of EGF or different types of inhibitors. We
calculated the standard error with bootstrapping (n = 1000, R package: boot).
Clustering
The time courses of the FIRE reporter (normalized) were clustered using Partitioning Around Medoids (PAM), which is a non-hierar-
chical clustering. PAM tries to partition the data by minimizing the squared error of distance measure (R package: cluster). We chose
Euclidean distance, which is based on the straight-line distance between the FIRE responses at each individual time-point. In order to
identify the most reasonable number of clusters, we calculated the Gap-statistic (Tibshirani et al., 2001)for an increasing number of
clusters (k = 1 ... 20) (R package: cluster).
Feature analysis
The time courses were separated into early (less than 16 h after stimulation) and late response (more than 20 h after stimulation). For
each signaling phase, we defined the amplitude as the mean of the three highest FIRE responses after normalization and the time of
response as themean time for the three highest FIRE responses. The fold-change is taken with respect to themean response of FIRE
in the same cell before stimulation. The log2 amplitude and the log2 fold-change were also included as features. The duration is
measured as full width at half maximum, limited to the maximum possible observation period. The area under the curve has been
estimated using a spline interpolation (R package: MESS). To identify responding cells, the amplitude of the first response and
the second response was compared to the distribution of the respective amplitude in the control experiment (without EGF).
Information theoretical analysis
For calculating the multivariate mutual information, we grouped each feature into equidistant bins. We calculated the overlap matrix,
or confusion matrix, between EGF concentrations and the different groups for each FIRE feature. A similar approach was used to
define the overlap between the different groups of FIRE features and whether a cell divides (yes-or-no decision). From this we calcu-
late mutual information, defined as
IðX;YÞ =
X
x˛X
X
y˛Y
pðx; yÞlog pðx; yÞ
pðxÞ$pðyÞ
We bootstrapped mutual information (n = 1000, R package: boot) to ensure robustness of the calculation and report the median.
Kaplan-Meier analysis
The analysis of duration of the S/G2-phase might be affected as cells are not monitored indefinitely and thus, we have incomplete
data. We are overcoming this shortcoming by calculating Kaplan-Meier curves. Kaplan-Meier curves are a way to analyze times-
to-event with incomplete data. This type of analysis is commonly used in clinical studies (Bewick et al., 2004) to account for
patient drop-outs. In the analysis of S/G2-phase duration, we characterize cells which go into S-phase if they undergo division (eventCell Reports 31, 107514, April 14, 2020 e4
occurrence) in themeasured time course or not (censored data). We show the cumulative events (completion of division) over time (R
package: survival, survminer).
Analysis of Luminex experiment with inhibitors
First, only valid beads are included for further analysis (> 90% of the beads). The experiment was done in two replicates and the sec-
ond replicate has a similar number of valid beads (> 90%) as the first one. The bead ids were mapped to the corresponding antibody
names of the Luminex assay. There were 534 (465) spurious beads with 26 (26) different ids. Those beads were removed from further
analysis. We bootstrapped the median (n = to calculate the amplitude and variability for each antibody. For each replicate the log2
fold-change compared to the untreated control has been calculated and the mean for the replicates is presented.
Analysis of EGF concentration
Fluorescence measurements of the EGF standard were used for a nonlinear regression (R-package: minpack.lm) of a 4-parameter
logistic function:
FI = d +
a d
1+
EGF
c
b
The parameters of the model fit were applied to the inverse function to map fluorescence intensities of the measurements in the
supernatant to EGF concentrations.e5 Cell Reports 31, 107514, April 14, 2020
